Articles with "death ligand" as a keyword



Photo from wikipedia

Programmed Death Ligand-1-Overexpressing Donor Exosomes Mediate Donor-Specific Immunosuppression by Delivering Co-inhibitory Signals to Donor-Specific T Cells.

Sign Up to like & get
recommendations!
Published in 2023 at "Advanced healthcare materials"

DOI: 10.1002/adhm.202300670

Abstract: Programmed death ligand-1 (PD-L1) and donor antigens are critical for donor immature dendritic cells (DCs) targeting donor-specific T cells to induce transplant tolerance. This study aimed to clarify whether DC-derived exosomes (DEX) with donor antigens… read more here.

Keywords: inhibitory signals; specific cells; donor specific; donor ... See more keywords
Photo by matmacq from unsplash

Programmed death ligand 1 testing in non–small cell lung carcinoma cytology cell block and aspirate smear preparations

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer Cytopathology"

DOI: 10.1002/cncy.21987

Abstract: Immune checkpoint inhibitors targeting the programmed cell death 1 (PD‐1) receptor and its ligand, programmed death ligand 1 (PD‐L1), have emerged as a therapeutic approach for patients with non–small cell lung carcinoma (NSCLC). PD‐L1 expression,… read more here.

Keywords: programmed death; cell; cytology; death ligand ... See more keywords
Photo from wikipedia

Clinical performance of endobronchial ultrasound‐guided transbronchial needle aspiration for assessing programmed death ligand‐1 expression in nonsmall cell lung cancer

Sign Up to like & get
recommendations!
Published in 2018 at "Diagnostic Cytopathology"

DOI: 10.1002/dc.23900

Abstract: Pembrolizumab was recently approved as a first line agent for metastatic NSCLC in patients with high programmed death‐ligand 1 (PD‐L1) expression. read more here.

Keywords: ligand expression; programmed death; death ligand;
Photo from wikipedia

Program death ligand‐1 immunocytochemistry in lung cancer cytological samples: A systematic review

Sign Up to like & get
recommendations!
Published in 2022 at "Diagnostic Cytopathology"

DOI: 10.1002/dc.24955

Abstract: In this era of personalized medicine, targeted immunotherapies like immune checkpoint inhibitors (ICI) blocking the programmed death‐1 (PD‐1)/program death ligand‐1 (PD‐L1) axis have become an integral part of treating advanced stage non‐small cell lung carcinoma… read more here.

Keywords: death ligand; lung; program death; cytology ... See more keywords
Photo from wikipedia

Detection of Programmed Cell Death Ligand 1 Expression in Lung Cancer Clinical Samples by an Automated Immunohistochemistry System.

Sign Up to like & get
recommendations!
Published in 2021 at "Methods in molecular biology"

DOI: 10.1007/978-1-0716-1278-1_4

Abstract: Programmed cell death 1 (PD-1) plays an important role in subsiding immune responses, in promoting self-tolerance through suppressing the activity of T-cells, and in promoting differentiation of regulatory T-cells. One of its ligands, programmed cell… read more here.

Keywords: cancer; death ligand; programmed cell; cell death ... See more keywords
Photo from wikipedia

Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

Sign Up to like & get
recommendations!
Published in 2020 at "Cancer Immunology, Immunotherapy"

DOI: 10.1007/s00262-020-02654-0

Abstract: Dendritic cell (DC)-based vaccines are recognized as a promising immunotherapeutic strategy against cancer; however, the efficacy of immunotherapy with DCs is controlled via immune checkpoints, such as programmed death-ligand 1 (PD-L1). PD-L1 expressed on DC… read more here.

Keywords: programmed death; dendritic cell; death ligand; myeloma ... See more keywords
Photo from wikipedia

Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma

Sign Up to like & get
recommendations!
Published in 2021 at "International Journal of Clinical Oncology"

DOI: 10.1007/s10147-021-01993-x

Abstract: Programmed death-ligand 1 (PD-L1) positivity is associated with poor prognosis in renal cell carcinoma (RCC). Because the prognostic impact and effect of confounding factors are less known, we investigated the prognostic significance of PD-L1 expression… read more here.

Keywords: status; renal cell; cell carcinoma; japanese patients ... See more keywords
Photo from wikipedia

The clinicopathological and prognostic value of programmed death-ligand 1 in colorectal cancer: a meta-analysis

Sign Up to like & get
recommendations!
Published in 2018 at "Clinical and Translational Oncology"

DOI: 10.1007/s12094-018-1970-9

Abstract: IntroductionProgrammed death-ligand 1 (PD-L1) is reportedly expressed in colorectal tumors. However, the prognostic role of PD-L1 in colorectal cancer (CRC) remains controversial. Therefore, we performed a meta-analysis to investigate the clinicopathological and prognostic impact of… read more here.

Keywords: colorectal cancer; death ligand; expression; cancer ... See more keywords
Photo from wikipedia

Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab.

Sign Up to like & get
recommendations!
Published in 2019 at "European journal of cancer"

DOI: 10.1016/j.ejca.2018.11.007

Abstract: BACKGROUND Recently, the Food and Drug Administration (FDA)/European Medicines Agency (EMA) restricted first-line use of atezolizumab and pembrolizumab in patients with metastasised urothelial carcinoma by defining distinct programmed cell death ligand-1 cut-offs. We analysed the… read more here.

Keywords: first line; atezolizumab pembrolizumab; death ligand; programmed cell ... See more keywords
Photo by matmacq from unsplash

Dendritic cell upregulation of programmed death ligand-1 via DNA demethylation inhibits experimental autoimmune encephalomyelitis.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of autoimmunity"

DOI: 10.1016/j.jaut.2019.102362

Abstract: Dendritic cells (DCs) play key roles in regulating T cell proliferation and differentiation, and epigenetic modification involves in this process. In the periphery, programmed death ligand-1 (PD-L1) expressed on antigen-presenting cells interacts with programmed death-1… read more here.

Keywords: dna; programmed death; death ligand; dna demethylation ... See more keywords
Photo by matmacq from unsplash

Programmed cell death ligand 1 expression is upregulated in the skeletal muscle of patients with myasthenia gravis

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Neuroimmunology"

DOI: 10.1016/j.jneuroim.2018.09.012

Abstract: We investigated the expression patterns of programmed cell death-ligand 1 (PD-L1) in the skeletal muscle of 15 patients with myasthenia gravis (MG). In 11 of the patients, immunohistochemistry confirmed the localization of PD-L1 in the… read more here.

Keywords: muscle; death ligand; programmed cell; expression ... See more keywords